Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis

Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis

Abstract Background Angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs) efficaciously reduce systolic blood pressure (BP), a well-established risk factor for myocardial infarction (MI). Both inhibit the renin-angiotensin system, albeit through different mecha...

Full description

Bibliographic Details
Main Authors: Jonathan A. Batty, Mengyao Tang, Marlous Hall, Roberto Ferrari, Martin H. Strauss, Alistair S. Hall
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Systematic Reviews
Subjects:
Angiotensin-converting enzyme inhibitors
Angiotensin receptor blockers
Hypertension
Blood pressure
Heart failure
Myocardial infarction
Online Access:http://link.springer.com/article/10.1186/s13643-018-0779-5

Internet

http://link.springer.com/article/10.1186/s13643-018-0779-5

Similar Items